Postpartum hypertension. Eclampsia in the puerperium
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cesarean candidate patients No chronic liver, kidney, hemorrhagic disorders No history of allergy to nonsteroidal anti-inflammatory drugs and acetaminophen Severe preeclampsia or preeclampsia added to chronic hypertension with severe symptoms
Exclusion criteria
Exclusion criteria: Increase in liver enzyme levels higher than 200 mg / dL Increase in serum creatinine higher than 2 mg / dL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary variable: Duration of high blood pressure. Timepoint: Measure blood pressure for 24 hours every hour and then every 4 hours. Method of measurement: Mercury sphygmomanometer.;Primary variable: Frequency of need to use short acting antihypertensive drugs. Timepoint: Measure blood pressure for 24 hours every hour and then every 4 hours. Method of measurement: Counting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of need to use short-acting antihypertensive drugs to control sudden hypertension in both groups receiving acetaminophen and nonsteroidal anti-inflammatory drugs. Timepoint: At the beginning of the study (before the intervention), for 24 hours every hour and then every 4 hours. Method of measurement: Counting. | — |
Countries
Iran (Islamic Republic of)
Contacts
Arak University of Medical Sciences